Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It was a tweet from @financilajuice1 from 32 mins ago
RUSSIAN GOLD PRODUCERS ARE LOOKING INTO EXPORTING TO THE UNITED ARAB EMIRATES AND CHINA.
RUSSIAN GOLD PRODUCERS ARE LOOKING INTO EXPORTING TO THE UNITED ARAB EMIRATES AND CHINA.
I suspect this tender could be for the Surescreen LFD. As Sensyne have already rolled out MagnifEye on a previous DHSC contract hopefully they will be awarded a chunk of this £6.5M. See details in the Bidstats link - https://bidstats.uk/tenders/2021/W38/759431521
£1.08p
I feel for all the holders that bought over £1. I have only three words..... Budd must go!
I feel for all of the sharholders that bought over £1. Three words.........Budd must go!
Steve Xerri buys 4.81% - the stock is becoming more tightly held.
Four of the fastest-growing stocks investors should buyExperts predict these companies will offer big rewards to adventurous investorsTrying to find the fastest-growing stocks in the hope they will become world-leading companies is not the right strategy for every investor. But for those investing for the long term, who can stomach violent share price swings, the rewards can be immense.Buying the right companies is no easy task, however. “Growth” investors search for companies that are growing their sales substantially every year. While they may not always be profitable, investors in these companies are betting that by getting in early, they will reap big rewards when their strong growth leads to profits.It can be a risky strategy, but fund managers believe the following stocks boast both the strong sales growth and resilient business models needed to make them compelling investments.Sensyne HealthBritish healthcare technology firm Sensyne Health uses anonymous patient data to accelerate the development of new medicines.Neil Goddin, manager of the Artemis Positive Future fund, said Sensyne was changing how drugs were developed and the treatment given to sick patients. “It has over 10 apps being used today, ranging from self-monitoring of blood glucose levels and coronavirus monitoring, right through to monitoring of heart failure. Now revenues are really taking off,” he said.The first year of sales – 2018 – generated £81,000 in revenue. In 2019 this grew by 68pc, before explosive growth last year, when revenue surged 1,500pc to more than £2m. By the end of 2024 sales are expected to have risen to £80m, according to Mr Goddin.Sensyne's share price performance offers a glimpse of how volatile growth stocks can be, however. After floating in 2018 at 175p per share, they tumbled to a low of just over 31p, before rising nearly five-fold to today's 150p price.
Great article in the Telegraph today recommending Sensyne Health as one of the four fasted growing stocks investors should buy!
https://www.telegraph.co.uk/investing/shares/four-fastest-growing-stocks-investors-should-buy/
I noticed there were two trade prints at £1.405 on Friday afternoon, one for £1M and one for just over £500K. I am unclear if they were sells or buys. Very strange as the share price didn't move.
Apologies if this has already been posted but i've just noticed Bidstats is showing a new contract of £144M for Innova. You couldn't make this up! https://bidstats.uk/tenders/2021/W28/754843819
Apologies if this has already been posted but i've just noticed that Bidstats is showing a new Innova contract for £144M. You couldn't make this up! https://bidstats.uk/tenders/2021/W28/754843819
@Brazos, do you have a link to the Analyst note relating to the price target?
One of the articles i read (i think it was from the original RNS confirming the agreement with Excalibur) stated the contract goes to Sensyne and then there is a revenue share agreed with Excalibur. Joining the dots here i believe that Excalibur looks to be the, or one of the 'sovereign tests' to be chosen by the government which means Sensysne's AI Tech will be used with the multi millions of lateral flow tests linbked through to the new App. I am surprised the market hasn't yet picked up on what could be about to happen once this is confirmed.
Hi All, does anyone have any information on what the value of the DHSC contract may be? I checked the Public contract awards on Bidstats and nothing shows up for Sensyne since the 3 x £247K awards in March, which is strange as the awards normally appear on this site before a company can issue an RNS.